Denosumab as a Treatment Alternative for Central Giant Cell Granuloma: A Long-Term Retrospective Cohort Study.

@article{Bredell2018DenosumabAA,
  title={Denosumab as a Treatment Alternative for Central Giant Cell Granuloma: A Long-Term Retrospective Cohort Study.},
  author={Marius Bredell and Tamara Rordorf and Sabine Kroiss and Martin Ruecker and Daniel Fritz Zweifel and Claudio Rostetter},
  journal={Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons},
  year={2018},
  volume={76 4},
  pages={775-784}
}
PURPOSE Giant cell granuloma (GCG) of the jaw is a rare disease with high morbidity. Various treatment options have been discussed in the past. Since 2010, a pharmaceutical therapy with denosumab seems to have been successful for giant cell tumors of the femur. The authors hypothesized the equally successful use of denosumab for GCGs of the jaws… CONTINUE READING